Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Université Laval

$90,000.00

Modeling blood-brain barrier dysfunctions using induced pluripotent stem cells: new insights into Huntington's disease pathology

EF 2019-20

Résumé
Huntington's disease (HD) is a strictly genetic disease which manifests with movement, cognitive and psychiatric problems. The dysfunctional protein that results from the genetic mutation, referred to as mutant huntingtin (mHtt), is found in all cells of the body, but it particularly affects the brain. Traditionally, it has been thought that the presence of the mutated gene is necessary for the disease to emerge. This view was radically changed by a recent discovery made by the Cicchetti group. When analysing fetal tissue that had been transplanted into patients with HD as an experimental therapy, they uncovered the presence of mHtt within the healthy cells of the graft. Since the fetal tissue did not express the mutant gene, the toxic form of the protein could only have come from the unhealthy tissue surrounding the transplant. This observation has many important implications, including the idea that the gene is not necessary for the initiation of disease. In association with mHtt in the fetal graft, they also found abnormalities in blood vessels. Normally blood vessels in the brain are surrounded by a barrier known as the blood brain barrier (BBB), which prevents toxins and other materials from reaching the brain. For my project, I will study the interactions between the protein associated with HD and changes in the function of the BBB. To do this, I will use a cell culture model of the BBB which closely resembles the BBB in the body in both cell composition and movement of fluids. Using this model, I will first measure how the presence of mHtt changes the function of the different parts of the BBB and second, determine if changes to the permeability of the BBB influences the negative effects that mHtt has on neurons. This project could shed light on new therapeutic targets for HD.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
413136
Name
Alpaugh Melanie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Modeling blood-brain barrier dysfunctions using induced pluripotent stem cells: new insights into Huntington's disease pathology
Programtype2
Fellowship Programs
Orgnameinp2
Université Laval
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Blood Brain Barrier; Huntington'S Disease; Ipscs; Mutant Huntingtin Protein; Organ-On-A-Chip
Abstract
Huntington's disease (HD) is a strictly genetic disease which manifests with movement, cognitive and psychiatric problems. The dysfunctional protein that results from the genetic mutation, referred to as mutant huntingtin (mHtt), is found in all cells of the body, but it particularly affects the brain. Traditionally, it has been thought that the presence of the mutated gene is necessary for the disease to emerge. This view was radically changed by a recent discovery made by the Cicchetti group. When analysing fetal tissue that had been transplanted into patients with HD as an experimental therapy, they uncovered the presence of mHtt within the healthy cells of the graft. Since the fetal tissue did not express the mutant gene, the toxic form of the protein could only have come from the unhealthy tissue surrounding the transplant. This observation has many important implications, including the idea that the gene is not necessary for the initiation of disease. In association with mHtt in the fetal graft, they also found abnormalities in blood vessels. Normally blood vessels in the brain are surrounded by a barrier known as the blood brain barrier (BBB), which prevents toxins and other materials from reaching the brain. For my project, I will study the interactions between the protein associated with HD and changes in the function of the BBB. To do this, I will use a cell culture model of the BBB which closely resembles the BBB in the body in both cell composition and movement of fluids. Using this model, I will first measure how the presence of mHtt changes the function of the different parts of the BBB and second, determine if changes to the permeability of the BBB influences the negative effects that mHtt has on neurons. This project could shed light on new therapeutic targets for HD.
Competitiondate
201910
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Alpaugh, Melanie
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~